23:10 , May 2, 2018 |  BC Extra  |  Preclinical News

UCSF study suggests stress response inhibitor could treat prostate cancer

A new study from University of California San Francisco researchers suggests that releasing the "brakes" on a tumor's stress regulation system by inhibiting eukaryotic translation initiation factor 2A (EIF2A) could help treat metastatic prostate cancer....
22:36 , Apr 4, 2018 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: March 2018

New Therapeutic Targets and Biomarkers: March 2018 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during March 2018. Therapeutic targets are defined as any protein, gene or other...
00:20 , Mar 7, 2018 |  BC Extra  |  Preclinical News

Calico team publishes on vanishing white matter disease

In a paper published in eLife , researchers from Calico Life Sciences LLC (South San Francisco, Calif.) and AbbVie Inc. (NYSE:ABBV) suggested that activating eukaryotic translation initiation factor 2B (EIF2B) could help treat vanishing white...